Apogee Therapeutics, Inc.
APGE
16 insider filings · Latest: May 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2024 | Oct 2 6:34 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 40,000 | $56.23 | $2.2M | — | View → |
| Sep 4, 2024 | Sep 4 5:35 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 40,000 | $47.62 | $1.9M | — | View → |
| Aug 23, 2024 | Aug 23 8:09 PM | JANE V HENDERSON | Proposed Sale | 6,000 | $48.26 | $289.6K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | May 9 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 123,040(D) | View → |
| Apr 16, 2026 | Apr 20 8:05 PM | Michael Thomas HendersonDirector, Chief Executive Officer | Option Exercise | 3,000 | $22.86 | 387,012(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 127,165(D) | View → |
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 131,290(D) | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 135,415(D) | View → |